Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDI-31244 + SOF/VEL in HCV GT1
NCT03501550Phase 2Completed
- Sponsor
- Cocrystal Pharma
- Start
- Jun 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CDI-31244 in hepatitis C (HCV), sponsored by Cocrystal Pharma. Started Jun 2018; status: completed.
02
Drugs
CDI-31244
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03501550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03501550.